Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers.

Saved in:
Bibliographic Details
Title: Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers.
Authors: Modi NB; Protagonist Therapeutics, Inc, Newark, California, USA., Cheng X; Protagonist Therapeutics, Inc, Newark, California, USA., Mattheakis L; Protagonist Therapeutics, Inc, Newark, California, USA., Hwang CC; Protagonist Therapeutics, Inc, Newark, California, USA., Nawabi R; Protagonist Therapeutics, Inc, Newark, California, USA., Liu D; Protagonist Therapeutics, Inc, Newark, California, USA., Gupta S; Protagonist Therapeutics, Inc, Newark, California, USA.
Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1263-1278. Date of Electronic Publication: 2021 May 04.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33942566
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Modi+NB%22">Modi NB</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Cheng+X%22">Cheng X</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Mattheakis+L%22">Mattheakis L</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Hwang+CC%22">Hwang CC</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Nawabi+R%22">Nawabi R</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Liu+D%22">Liu D</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Protagonist Therapeutics, Inc, Newark, California, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572899%22">Clinical pharmacology in drug development</searchLink> [Clin Pharmacol Drug Dev] 2021 Nov; Vol. 10 (11), pp. 1263-1278. <i>Date of Electronic Publication: </i>2021 May 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572899 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2160-7648 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222160763X%22">2160763X </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Drug Dev <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33942566
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cpdd.946
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1263
    Titles:
      – TitleFull: Single- and Multiple-Dose Pharmacokinetics and Pharmacodynamics of PN-943, a Gastrointestinal-Restricted Oral Peptide Antagonist of α4β7, in Healthy Volunteers.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Modi NB
      – PersonEntity:
          Name:
            NameFull: Cheng X
      – PersonEntity:
          Name:
            NameFull: Mattheakis L
      – PersonEntity:
          Name:
            NameFull: Hwang CC
      – PersonEntity:
          Name:
            NameFull: Nawabi R
      – PersonEntity:
          Name:
            NameFull: Liu D
      – PersonEntity:
          Name:
            NameFull: Gupta S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2021 Nov
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 2160-7648
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Clinical pharmacology in drug development
              Type: main
ResultId 1